Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study
Theodore D. Ruel, Edmund V. Capparelli, Camlin Tierney, Bryan S. Nelson, Anne Coletti, Yvonne Bryson, Mark F. Cotton, Stephen A. Spector, Mark Mirochnick, Rebecca LeBlanc, Christina Reding, Bonnie Zimmer, Deborah Persaud, Mutsa Bwakura-Dangarembizi, Kimesh L. Naidoo, Rohan Hazra, Patrick Jean-Philippe, Ellen G. Chadwick
Dive into the research topics of 'Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study'. Together they form a unique fingerprint.